SC 13G Filing

Company

GYRE THERAPEUTICS, INC.

Filed

March 4, 2022

Accession Number

0000935836-22-000227

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →